Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | July 25, 2023 01:31pm

Gainers

  • Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved upwards by 33.8% to $4.63 during Tuesday's regular session. Trading volume for Bullfrog AI Hldgs's stock is 42.6 million as of 13:30 EST. This is 8458.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.2 million.
  • Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock rose 32.66% to $19.82. Trading volume for Kiniksa Pharmaceuticals's stock is 3.0 million as of 13:30 EST. This is 719.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 billion. As per the press release, Q2 earnings came out today.
  • Galecto (NASDAQ:GLTO) shares rose 28.51% to $3.02. As of 13:30 EST, this security is trading at a volume of 2.5 million shares, making up 3286.3% of its average full-day volume over the last 100 days. The company's market cap stands at $77.5 million.
  • Armata Pharmaceuticals (AMEX:ARMP) shares rose 23.56% to $1.94. As of 13:30 EST, Armata Pharmaceuticals's stock is trading at a volume of 294.2K, which is 594.9% of its average full-day volume over the last 100 days. The company's market cap stands at $70.1 million.
  • Genelux (NASDAQ:GNLX) shares rose 20.12% to $24.35. Genelux's stock is trading at a volume of 54.3K shares as of 13:30 EST. This is 125.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $632.7 million.
  • Akebia Therapeutics (NASDAQ:AKBA) shares increased by 18.44% to $1.45. As of 13:30 EST, Akebia Therapeutics's stock is trading at a volume of 5.6 million, which is 298.4% of its average full-day volume over the last 100 days. The company's market cap stands at $268.6 million.

Losers

  • Humanigen (NASDAQ:HGEN) stock fell 77.1% to $0.04 during Tuesday's regular session. The current volume of 90.6 million shares is 5964.9% of Humanigen's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $5.2 million.
  • Bellerophon Therapeutics (NASDAQ:BLPH) shares decreased by 39.27% to $0.43. Bellerophon Therapeutics's stock is trading at a volume of 2.5 million shares as of 13:30 EST. This is 466.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 million.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock fell 33.65% to $1.05. Trading volume for this security as of 13:30 EST is 1.3 million, which is 824.4% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million.
  • Stoke Therapeutics (NASDAQ:STOK) shares declined by 33.53% to $6.33. Trading volume for Stoke Therapeutics's stock is 3.8 million as of 13:30 EST. This is 1495.0% of its average full-day volume over the last 100 days. The company's market cap stands at $279.9 million.
  • 9 Meters Biopharma (NASDAQ:NMTR) stock fell 32.86% to $0.09. The current volume of 3.0 million shares is 686.4% of 9 Meters Biopharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.2 million.
  • Tarsus Pharmaceuticals (NASDAQ:TARS) stock decreased by 24.74% to $18.05. The current volume of 2.1 million shares is 1005.2% of Tarsus Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $483.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKBA ARMP BFRG BLPH GLTO GNLX HGEN KNSA NMTC NMTR STOK TARS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist